Novan NOVN

Quarterly report 2023-Q1
added 05-15-2023

Novan DIO Ratio 2011-2026 | NOVN

Annual DIO Ratio Novan

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
29.6	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
29.6	29.6	29.6

Quarterly DIO Ratio Novan

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
82.1	-	86.7	53	327	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
327	53	137

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	MannKind Corporation MNKD	430	$ 3.56	24.48 %	$ 1.09 B	USA
	Bio-Techne Corporation TECH	157	$ 47.41	-16.36 %	$ 7.47 B	USA
	United Therapeutics Corporation UTHR	162	$ 596.76	4.29 %	$ 26.4 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Exelixis EXEL	96.1	$ 48.7	9.64 %	$ 13.2 B	USA
	ACADIA Pharmaceuticals ACAD	295	$ 21.48	-3.89 %	$ 3.56 B	USA
	Fortress Biotech FBIO	210	-	-	$ 71.1 M	USA
	Esperion Therapeutics ESPR	2.46 K	$ 3.15	1.19 %	$ 655 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.17	3.2 %	$ 3.08 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.7	3.66 %	$ 452 M	Britain
	Завод ДИОД DIOD	768	-	-	-	Russia